Articles tagged with Cancer
Researchers found radiofrequency ablation to be 93% effective in eradicating malignant kidney tumors, with minimal discomfort and no serious complications. The study's lead author suggests this treatment is an excellent option for patients who are not good operative candidates or have multiple renal tumors.
Scientists at CSIRO Australia are exploring the use of a new synchrotron to detect biochemical changes in Tasmanian devil hair that could indicate facial tumour disease. This could lead to the development of an early detection test, making quarantine strategies more efficient and effective.
A study of 125 kidney tumors treated with radiofrequency ablation showed a high cure rate and low complication rate. The procedure achieved a 93% success rate for all treated tumors, making it an alternative method for patients who are not good surgical candidates.
UC Irvine scientists use mathematical theory to understand how cancer cells alter their genetic makeup, accelerating tumor growth. The study found that tumors thrive when unstable in early stages and become stable later on, providing insight into future cancer treatments.
St. Jude researchers used a new technique to monitor the movement of DNA repair proteins as they interacted with each other and gathered at the site of damage. The study found that disruption of these proteins can cause mutations, cell death, or cancer, providing critical insights into DNA repair mechanisms.
Young males are disproportionately affected by road traffic accidents, with those under 25 nearly three times more likely to die than women in the same age group. The World Health Organisation reports an estimated 1.2 million annual deaths worldwide due to RTAs.
Researchers at Texas A&M University are studying fruit flies to understand cellular differentiation and chromosome counting. They hope to uncover mechanisms that can help shed light on human genetic maladies such as color blindness and hemophilia.
In ICU, multiple organ failure is the main cause of death, with central nervous system and cardiovascular failures being significant risk factors. In hospitals after ICU discharge, malignant tumors and exacerbation of cardiovascular disease are leading causes of death.
A Montréal research group identified two essential components of negative feedback control in hormone regulation, which are deficient in about half of pituitary tumors from Cushing disease patients. This finding provides a molecular explanation for hormone resistance and may lead to better management of the condition.
A new study found that black patients with bladder cancer are 35 percent more likely to die of the disease than white patients. Black women in particular had more aggressive tumors and lower survival rates compared to white men and women and black men.
The Microscale Life Sciences Center at ASU has been awarded a five-year $18 million grant to continue its research on cell growth and death, aiming to understand the nature of disease processes. The center will develop miniature automated systems to analyze differences between healthy and diseased body cells.
Inhibiting ERK1 enhances ERK2 activity, promoting cell proliferation, while ERK2 knockdown almost completely abolishes it. Mouse tumour cells expressing only ERK1 grow into small tumours.
A recent study found that differences in HD types across regions play a major role in determining regional survival rates. Analysis revealed no significant difference in mortality risk between EUROCARE-west and the US SEER databases when adjusting for morphology, but morphology accounted for differences in EUROCARE-UK and EUROCARE-east...
A new study from the University of Michigan finds that patients often struggle to access reliable medical information online. Librarians play a crucial role in helping patients find quality resources, providing expertise and accessing specialized databases not available to the general public.
Researchers have developed a new method for detecting brain tumours during surgery using a fluorescent compound, which significantly improves complete tumour removal rates (65% vs 36%) and survival rates without tumour progression (41% vs 21%). The technique has been shown to be safe with no significant difference in serious side effects.
Researchers are working on developing new diagnostic tools using nanotechnology to identify biomarkers for diseases. This could lead to earlier detection and more effective treatment, reducing the economic and social impact of diseases.
Researchers used Genomatix technology to identify new genes associated with renal disease, using comparative promoter analysis to predict cell junction proteins in the glomerular slit diaphragm. The approach effectively predicted a previously unrecognized molecule, which was experimentally verified.
The Australian government has pledged $50 million to support the expansion of the Walter and Eliza Hall Institute's (WEHI) research capabilities in cancer and infectious disease. This funding will enable significant expansions in the institute's research programs, focusing on targeted therapies for cancer treatment and malaria control.
Researchers found that FOP is misdiagnosed 87% of the time, taking an average of four years to be accurately diagnosed. Inaccurate diagnoses led to painful biopsies and incorrect treatments, often worsening the condition and resulting in permanent loss of mobility.
A new study has found that large sinus tumors can be successfully removed endoscopically, with a significant reduction in morbidity compared to traditional open procedures. The procedure involves using tiny scopes and cameras to remove the tumor, which was shown to have a lower recurrence rate than expected.
Research reveals PTEN regulates VGF signaling, enhancing angiogenesis and accelerating tumor growth in mice. Individuals with mutated PTEN alleles are at risk for increased tumorigenic mutations and accelerated tumor growth due to enhanced angiogenesis.
Researchers at Rice University developed a new nanoprobe that uses quantum dots to visualize proteolytic activity in vivo, solving the problem of distinguishing between disease signals and background noise. The probes are activated by enzymes associated with specific diseases, allowing for early detection and monitoring.
Researchers at Georgetown University Medical Center have developed a cutting-edge matrix assembly technology to analyze large numbers of tumors. The new method allows scientists to discover and detect unique biomarkers of disease in patients, leading to more accurate patient diagnosis and treatment.
Research reveals that SV40 large T antigen binds to tumor suppressor Fbw7, hijacking its function to promote tumorigenesis. This interaction highlights the importance of Fbw7 as a potential therapeutic target for cancer treatment strategies.
Dr. Erkki Ruoslahti's pioneering work on cell adhesion has led to significant discoveries in cancer biology and its applications to various diseases. His contributions have elucidated the etiology and developed therapy for serious conditions like malignant tumors, heart attack, stroke, and osteoporosis.
Researchers propose a new approach to understanding epigenetics in common diseases, such as cancer, diabetes, and heart disease. The framework aims to analyze epigenetic marks across the entire genome, revealing their role in disease variability and progression.
Analysis of Croatian skeletal remains reveals only four cases of neoplastic disease, with all three conditions being benign. The study highlights the increasing incidence of cancer due to increased life expectancy and lifestyle factors.
A new combined PET/CT scanner has shown significant improvement in tumor staging accuracy compared to traditional CT and PET imaging methods. The study involved 260 patients with various oncological diseases, yielding accurate staging results in 84% of cases.
Researchers from USC provide a new perspective on treating genetic disorders by switching genes back on using epigenetic therapy. Several chemical compounds have been found to affect epigenetic gene changes and are being tested in clinical trials, including one recently approved for myelodysplastic syndrome.
A new dynamic PET technique has been developed to provide more accurate diagnoses and improve patient comfort during PET scans. By combining a short initial scan with a longer static scan, doctors can gather valuable data about cancer tumors and treatment response.
Researchers have identified over 2,700 genes with unusual activity in people with scleroderma, a mysterious skin disease. The study's findings suggest the disease is systemic, not confined to visible skin patches, and may lead to improved diagnosis and targeted treatment options.
Researchers found that postmenopausal women who engaged in moderate-intensity exercise experienced significant reductions in weight, total body fat, and intra-abdominal fat. The study's large sample size and high adherence rates make it a significant finding for older women seeking to reduce their risk of chronic disease.
Researchers found that indomethacin reduced postoperative tumor growth by up to 63% in female and male rats. The study suggests controlling pain and inflammation may be crucial in managing cancer patients undergoing surgery.
A new study of 59 chronically ill children reveals that well-adjusted and supportive mothers are less likely to experience depression in their children. Children with stable caregiver relationships tend to cope better with chronic pain, suggesting early interventions for struggling caregivers could benefit the entire family.
A study of 77 twin pregnancies found that women who chose to continue their pregnancy despite a hydatidiform mole experienced a 40% chance of a successful outcome. This choice was associated with a relatively small chance of serious obstetric complications and did not increase the risk of developing malignant disease.
A study on twin pregnancies with a hydatidiform mole found that women who continue the pregnancy have a 40% chance of a successful outcome. The risk of serious obstetric complications is relatively small, and malignant disease does not appear to increase in this group
A new wireless imaging test has been developed to identify the source of gastrointestinal bleeding, enabling earlier treatment. The test, using a video capsule, was successful in diagnosing conditions not previously detected by conventional tests in 76% of cases.
A study of 271 patients with pheochromocytomas found that 24% carried one or more genetic mutations, including those in the VHL and RET genes. These mutations were associated with earlier symptom onset, multiple tumors, and specific tumor profiles.
Research suggests that defects in 'orphan' inositol polyphosphates may contribute to diseases such as manic depression and cancer. Dr. York's work identifies biological roles for these molecules and provides a basis for designing more specific drugs with fewer side effects.
Robert Eisenman, a leading oncogene expert, has made significant contributions to understanding how normal cells become cancerous and impacted studies of AIDS and other diseases. He will receive the award at the AACR annual meeting in San Francisco.
Researchers discovered a small molecular variation that inactivates the neurofibromin tumor suppressor gene, leading to increased tumor development. The finding suggests a new mechanism by which RNA editing can disable tumor-suppressing genes, potentially contributing to cancer progression.
A Phase II study demonstrates the efficacy of non-surgical radiologic intervention using heat in treating kidney cancers. Dr. Jonathan Lewin has successfully 'ablated' tumors in six patients with no recurrence, surpassing the normal three- to-six-month recurrence rate.
The environment plays a significant role in cancer development, with occupational factors and environmental pollution attributed to 5-7% of cancer deaths. Dr. Richard Clapp reviews the relationship between environmental exposure and cancer, emphasizing the importance of cancer prevention and physician screening for hazardous exposures.
Researchers at the University of Pennsylvania Cancer Center have successfully conducted a Phase I clinical trial on combretastatin A4 phosphate, a vascular targeting agent. The study found that patients with solid tumors were able to safely tolerate the treatment and showed evidence of decreased blood flow to the tumor.
The researchers created mouse models with benign and malignant NF1-related tumors to study the disease. The studies revealed that neurofibroma tumors invariably include cells lacking the NF1 gene, and that anti-Ras drugs might be useful in treating NF1.
Researchers at Yale University have successfully characterized the function of yeast genes, providing new insights into how human cells work. The study's findings could lead to better understanding and treatment of diseases like cancer.
Researchers at Thomas Jefferson University describe the workings of an enzyme caspase-9 crucial for understanding apoptosis. They hope to develop drugs that inhibit this enzyme to fight neurodegenerative diseases.
Scientists at NIH developed a new drug that reduces tumor size without severe side effects. In a clinical trial, 9 of 15 patients had significant tumor regression, with complete disappearance in two cases. A related therapy using virus-producing cells also showed promise, but only for small tumors.
Stephen Schneider proposes a 'meta-institution' to evaluate scientific assertions and urges citizens to ask experts for information. He recommends asking three questions: What can happen, what are the odds, and how do you know?, to help navigate complex decisions.